National ANTIBIOTIC RESISTANCE Portal
Private Collaborative Access

French National ANTIBIOTIC RESISTANCE Portal

Editorial by Isabelle TONGIO

The emergence and development of antibiotic resistance is mainly linked to the inappropriate use of antibiotics.
In vitro diagnostic systems and tests, because they detect and identify pathogens and assess their sensitivity to certain antibiotics, make it possible to implement appropriate specific treatment: in that regard, they play an essential role in the fight against antibiotic resistance.
Read more

A call for action launched at the international symposium “Research and innovation to reduce the burden of antibiotic resistance” in Paris, on June 07, 2022

“If nothing is done, antibiotic resistance will cause more deaths than cancer or cardiovascular diseases in 2050” stated Stewart Cole, CEO of the Institut Pasteur, at the opening of the international symposium “Research and innovation to reduce the burden of antibiotic resistance” jointly organised by Inserm and Institut Pasteur. This event was held on June 7th, 2022, at PariSanté Campus in Paris, France.
Read more

Countering antibiotic resistance: a research and health priority

Antimicrobial resistance is a global phenomenon that knows no geographical or species boundaries and poses a significant threat to human, animal and environmental health. It is a particularly complex and growing problem, threatening our ability to treat bacterial infections.
Read more

PSFC: Projects on antibiotic resistance are eligible

Within the framework of the Priority Research Programme (PPR) on antimicrobial resistance, a budget of €1.5M was dedicated to the structuring and coordination of a network on antibiotic resistance with countries with limited resources, aiming to federate local and French forces in order to develop research and facilitate applications to calls for projects for the financing of joint research projects.
Read more

5 documentary videos on antimicrobial resistance

During the national conference on antimicrobial resistance, organised by Inserm on Monday 22 November in Aubervilliers, 5 documentary videos were shown, produced by the company La Jolie Prod, which you can watch in streaming.
Read more

Why a french national ANTIBIOTIC RESISTANCE portal?

The French National Antibiotic Resistance portal, which results from the PPR on Antibiotic Resistance, is intended for the scientific community as a common, intersectoral and interactive gateway. It identifies public and private actors, platforms and networks, coordination activities, events and research projects in the field on antibiotic resistance.

Projects and actions supported

The PPR on Antimicrobial Resistance funds for €40M, 11 research projects, a meta-network of professionals, a multi-omics data platform, a digital observatory of social dimensions and research positions.
See all funded projects

Priority Research Programme on
ANTIBIOTIC RESISTANCE

First call for projects of the Antibiotic resistance programme

Governance and coordination

Microbiology and multi-omics data platform

Meta-network of professionals

Observatory dedicated to social sciences

Research network with low- and middle-income countries

“One Health”


The “One Health” approach conceptualises
human, animal and environmental health as
one, integrated system. As dissemination of
resistant bacteria between humans, animals and
the environment is a key factor in the spread of
antibiotic resistance, it is essential to develop
control strategies that do not dissociate humans
from their environment. This underlines
the urgent need to support a holistic
research response to challenges in
these three sectors.

News

See all the news

Our videos

Priority Research Program (PPR) Antibiotic resistance

Could we die tomorrow from a common infection for lack of effective treatment? Antibiotic resistance has become an enormous public health problem, with interdependence between humans, animals and the environment.

Antibioresistance: structuring tools and networks

The Priority Research Program (PPR) for antibiotic resistance includes optimization of use, therapeutic innovation, control of emergence… But that’s not enough.

See more

Controlling the emergence of antibiotic resistance

To limit the development of antibiotic resistance, we can optimize uses, innovate with new treatments, but also call on the human and social sciences.